Vives Fund is the famous VC, which was founded in 2004. The company was established in Europe in Belgium. The leading representative office of defined VC is situated in the Louvain-la-neuve.
Among the most popular portfolio startups of the fund, we may highlight Tessares, Keemotion, Olygose. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are iOS, Nutrition. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Vives Fund, startups are often financed by XMP Business Angels, Investment Arm, Proximus Group, KREAXI. The meaningful sponsors for the fund in investment in the same round are S.R.I.W., Nivelinvest, Iris Capital. In the next rounds fund is usually obtained by R/GA Ventures, Global Sports Venture Studio, Pincus Capital Management.
The high activity for fund was in 2017. The common things for fund are deals in the range of 5 - 10 millions dollars. Speaking about the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year.
We also calculated 1 valuable employee in our database.
Related Funds
Fund Name | Location |
Black Powder | - |
Daum-Kakao Youth Growth Fund | - |
FinStart Nordic | - |
Health Evolution Partners | California, San Francisco, United States |
Humania Assurance | Canada, Quebec, Saint-hyacinthe |
Insight Investment | England, London, United Kingdom |
Investing Profit Wisely | - |
Joyful Ascent | - |
NDCapital | California, Los Angeles, United States |
YYX Capital | England, London, United Kingdom |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Sunrise | $20M | 09 Mar 2023 | Brussels, Brussels Hoofdstedelijk Gewest, Belgium | ||
Novadip Biosciences | $28M | 03 Nov 2022 | Belgium, Walloon Brabant, Belgium | ||
BOTALYS | $7M | 04 Oct 2022 | Ghislenghien, Hainaut, Belgium | ||
Spinovit | 01 Jan 2022 | - | |||
Sunrise | $7M | 15 Dec 2021 | Brussels, Brussels Hoofdstedelijk Gewest, Belgium | ||
Novadip Biosciences | $22M | 28 Oct 2021 | Belgium, Walloon Brabant, Belgium | ||
Aphea.Bio | $21M | 14 Apr 2021 | Ghent, East Flanders, Belgium | ||
Aphea.Bio | $4M | 01 Apr 2021 | Ghent, East Flanders, Belgium | ||
Syndesi Therapeutics | $7M | 28 Sep 2020 | Belgium, Limburg, Belgium |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Sunrise | $20M | 09 Mar 2023 | Brussels, Brussels Hoofdstedelijk Gewest, Belgium | ||
Novadip Biosciences | $28M | 03 Nov 2022 | Belgium, Walloon Brabant, Belgium | ||
BOTALYS | $7M | 04 Oct 2022 | Ghislenghien, Hainaut, Belgium | ||
Spinovit | 01 Jan 2022 | - | |||
Sunrise | $7M | 15 Dec 2021 | Brussels, Brussels Hoofdstedelijk Gewest, Belgium | ||
Novadip Biosciences | $22M | 28 Oct 2021 | Belgium, Walloon Brabant, Belgium | ||
Aphea.Bio | $21M | 14 Apr 2021 | Ghent, East Flanders, Belgium | ||
Aphea.Bio | $4M | 01 Apr 2021 | Ghent, East Flanders, Belgium | ||
Syndesi Therapeutics | $7M | 28 Sep 2020 | Belgium, Limburg, Belgium |